GlassScriptPhysician profile
Jun Li Sharon Cai
NPI 1851820534
$615.04
in general payments reported to CMS, 2019-2025
12 companies · $114 in 2025
The $114 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $115 · 2022: $114 · 2023: $132 · 2024: $140 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $197.75 | 2021-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Sobi, INC | $74.33 | 2021-2023 | |
| Pfizer INC. | $73.66 | 2021-2025 | |
| Glaxosmithkline, LLC. | $49.13 | 2022-2023 | Bexsero |
| Sarepta Therapeutics, INC. | $44.68 | 2022-2024 | Elevidys |
| Cranial Technologies, INC | $38.29 | 2022-2024 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $35.56 | 2021 | |
| Seqirus USA INC | $23.42 | 2023 | Flucelvax Quadrivalent |
| Supernus Pharmaceuticals, INC. | $22.27 | 2021 | |
| Sanofi-Aventis U.S. LLC | $20.30 | 2025 | |
| Alk-Abello, INC | $19.61 | 2025 | Neffy |
| Verrica Pharmaceuticals INC. | $16.04 | 2025 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jun Li Cai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.